Cilengitide is a cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis.
Related Prodcuts:
Dynorphin A (1-13); Deslorelin; Gonadorelin; Gonadorelin acetate; Sermorelin; Sermorelin Acetate; Etelcalcetide; DSIP; Lixisenatide; Angiotensin acetate; Epithalone; Buserelin; Cilengitide; Tesamorelin; Selank; ACTH (1-39) Seractide; Ipamorelin